Picture of Asia Green Biotechnology logo

ASIA Asia Green Biotechnology Income Statement

0.000.00%
ca flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Annual income statement for Asia Green Biotechnology, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.

2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue00000
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses0.9220.7670.5530.5230.179
Operating Profit-0.922-0.767-0.553-0.523-0.179
Total Net Non Operating Interest Income / Expense
Net Income Before Taxes-0.922-0.767-0.553-0.525-0.198
Net Income After Taxes-0.922-0.767-0.553-0.525-0.198
Net Income Before Extraordinary Items
Net Income-0.922-0.767-0.553-0.525-0.198
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income-0.922-0.767-0.553-0.525-0.198
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS-0.058-0.031-0.02-0.016-0.005
Dividends per Share